Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0699790 (
colon cancer
)
28,837
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Acquisition of cell migration capacity is an early and essential process in cancer development. The aim of this study was to identify microRNA gene expression networks that induced high migration capacity. Using
colon cancer
HCT116 cells subcloned by transwell-based migrated cell selection, microRNA array analysis was performed to examine the microRNA expression profile. Promoter activity and microRNA targets were assessed with luciferase reporters. Cell migration capacity was assessed by either the transwell or scratch assay. In isolated subpopulations with high migration capacity, the expression levels of the
miR-23b/27b/24
cluster increased in accordance with the increased expression of the short
C9orf3
transcript, a host gene of the
miR-23b/27b/24
cluster. E2F1-binding sequences were involved in the basic transcription activity of the short
C9orf3
expression, and E2F1-small-interfering (si)RNA treatment reduced the expression of both the
C9orf3
and
miR-23b/27b/24
clusters. Overexpression experiments showed that
miR-23b
and
miR-27b
promoted cell migration, but the opposite effect was observed with
miR-24
. Forkhead box P2 (FOXP2) mRNA and protein levels were reduced by both/either
miR-23b
and
miR-27b
. Furthermore, FOXP2 siRNA treatment significantly promoted cell migration. Our findings demonstrated a novel role of the
miR-23b/27b/24
cluster in cell migration through targeting FOXP2, with potential implications for the development of microRNA-based therapy targeted at inhibiting cancer migration.
...
PMID:The MicroRNA-23b/27b/24 Cluster Facilitates Colon Cancer Cell Migration by Targeting FOXP2. 3193 44